2024 Helen Walker Research Grant Award

Boston Children's Hospital, Harvard Medical School | Jaymin Upadhyay, PhD

Supporting research aimed at improving at-home functional biomarker assessment for Pompe disease.

Back to Helen Walker Research Grant

Quick Facts

Year Awarded:

2024

Funding Amount:

$150,000

Lead Investigator:

Jaymin Upadhyay, PhD

Institution:

Boston Children’s Hospital, Harvard Medical School

Research Focus:

Clinical outcomes and digital health monitoring

Status:

Ongoing

Project Title

Implementation of At-Home Functional Biomarker Methods in Patients with Pompe Disease

Project Snapshot

In 2024, the AMDA awarded the Helen Walker Research Grant to Jaymin Upadhyay, PhD, at Boston Children’s Hospital, Harvard Medical School, to support a project focused on developing at-home biomarker methods for individuals with Pompe disease. The project centers on identifying non-invasive approaches to monitor muscle health, motor function, speech, cognition, and respiratory function.

The research aims to validate a set of at-home assessments that can be used longitudinally to track disease progression and treatment response. Using a combination of wearable and portable technologies, clinical testing methods, and patient-reported measures, the study is designed to improve accessibility and frequency of monitoring in Pompe disease.

Research Objectives

The project aimed to address several key questions related to treatment outcomes in Pompe disease:

1. Identifying at-home methods to longitudinally monitor muscle health, (fine-)motor performance, and respiratory function

Researchers will evaluate wearable and portable technologies capable of tracking changes in muscle strength, fine- and gross- motor performance, and respiratory function outside of a clinical setting. Assessments will be administered to individuals with both infantile-onset Pompe disease (IOPD) and late-onset Pompe disease (LOPD), with the goal of identifying tools that are sensitive enough to detect meaningful change over time and feasible for repeated use in the home environment.

2. Identify at-home methods to longitudinally monitor speech production and cognitive performance

The study will evaluate digital and portable assessment tools designed to capture changes in speech production and cognitive function in individuals with IOPD and LOPD. Because these domains are not routinely measured in standard clinical visits, this objective aims to establish reliable, accessible approaches that can be used frequently and independently by patients, providing a more complete picture of disease progression across multiple symptom areas.

3. Identify at-home methods to longitudinally monitor bulbar functioning

Researchers will assess the feasibility and viability of at-home tools for monitoring bulbar function — including swallowing and oral motor control — in individuals with IOPD and LOPD. Bulbar involvement can significantly affect quality of life and nutritional health, yet it is often under-monitored between clinic visits. This objective seeks to identify measurement approaches that can capture changes in bulbar functioning with sufficient sensitivity to support clinical decision-making and treatment evaluation.

Why This Matters

Pompe disease leads to a range of motor, cognitive, and respiratory impairments that can be difficult to monitor consistently over time. Current evaluation methods, such as in-clinic testing and imaging, may not be accessible or feasible for all individuals. This research aims to improve disease monitoring by developing flexible, at-home biomarker tools that can capture changes in multiple symptom domains. More accessible and frequent assessment may support earlier intervention, improved treatment decisions, and a better understanding of disease progression in individuals living with Pompe disease.

Research Team

Institution

Boston Children’s Hospital, Harvard Medical School, United States

Lead Investigator

Jaymin Upadhyay, PhD
Assistant Professor

Co-Investigators

Raquel van Gool, MSc
Benjamin Goodlett, PhD
Julie Shulman, PhD
Walla Al-Hertani, MD
Seward Rutkove, MD
Buket Sonbas Cobb, PhD
Adam Vogel, Phd

Lead Investigator

Jaymin Upadhyay, PhD
Assistant Professor

Co-Investigators

Raquel van Gool, MSc
Benjamin Goodlett, PhD
Julie Shulman, PhD
Walla Al-Hertani, MD
Seward Rutkove, MD
Buket Sonbas Cobb, PhD
Adam Vogel, Phd

Grant Support

The AMDA awarded $150,000 through the Helen Walker Research Grant to support this project.

Funding supported partial salary support for a post-doctoral trainee; acquisition of at-home testing equipment, including electrical impedance myography systems, tablets, dynamometers, and assessment tools; disposable sensors and testing materials; digital licenses for data acquisition and analysis platforms; study participant remuneration; cloud-based data storage and computing services; publication costs; travel support for study implementation and dissemination; and shipping of study kits to and from participant homes.

Publications Resulting from This Research

This section will be updated as we collect more information about publications resulting from this research.

Related Outputs

This section will be updated as we collect more information about presentations, follow-up studies, or related outputs from this project.

Ongoing Impact

Research supported by the Helen Walker Research Grant helps build knowledge that can shape future studies, clinical care, and treatment strategies in Pompe disease. As additional publications, presentations, and follow-up work emerge, this page will continue to be updated.

About the Helen Walker Research Grant

The Helen Walker Research Grant honors Helen Walker, a dedicated patient advocate and leader in the Pompe community. Through this grant, the AMDA supports innovative research aimed at improving understanding, treatment, and care for individuals living with Pompe disease.

Explore more Helen Walker Research Grant awardees and the growing body of Pompe research supported by the AMDA.